Lawsuits Mount; Philly-Area Pharma Company Reports 20,000-Related Opioid Deaths to the FDA

Article about adverse event reports for opioid painkillers such as Opana quotes ISMP expert on weaknesses in the monitoring system for drug-related deaths in the U.S.

For the full text, visit the Philadelphia Inquirer online.